GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | 8/10/2026 7:06:20 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $218,375,000 +45.5% | Assets $761,447,000 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/4/2026 5:11:17 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $191,203,000 +57.4% | Assets $713,607,000 | EPS -$1.26 | |
| Axsome Therapeutics, Inc. (AXSM) | 5/4/2026 7:08:55 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $191,203,000 +57.4% | Assets $713,607,000 | EPS -$1.26 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 4/24/2026 5:08:11 PM | View | Proxy | SEC | Y 2025 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 2/23/2026 5:16:02 PM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $638,496,000 +65.5% | Assets $689,805,000 | EPS -$3.68 | |
| Axsome Therapeutics, Inc. (AXSM) | 2/23/2026 7:18:31 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $195,999,000 +65.0% | Assets $689,805,000 | EPS -$0.55 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 1/12/2026 7:10:15 AM | View | Financials | Earnings (Prelim) | SEC | Y 2025 | Export Earnings Model | ||||
| Axsome Therapeutics, Inc. (AXSM) | 11/3/2025 4:44:31 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $170,992,000 +63.2% | Assets $669,250,000 | EPS -$0.94 | |
| Axsome Therapeutics, Inc. (AXSM) | 11/3/2025 7:08:04 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $170,992,000 +63.2% | Assets $669,250,000 | EPS -$0.94 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 8/4/2025 5:36:21 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $150,042,000 +72.1% | Assets $639,785,000 | EPS -$0.97 | |
| Axsome Therapeutics, Inc. (AXSM) | 8/4/2025 7:44:50 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $150,042,000 +72.1% | Assets $639,785,000 | EPS -$0.97 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 5/5/2025 4:53:04 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $121,463,000 +62.0% | Assets $596,671,000 | EPS -$1.22 | |
| Axsome Therapeutics, Inc. (AXSM) | 5/5/2025 7:34:29 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $121,463,000 +62.0% | Assets $596,671,000 | EPS -$1.22 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 4/25/2025 4:43:41 PM | View | Proxy | SEC | Y 2024 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 2/18/2025 5:26:26 PM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $385,693,000 +42.5% | Assets $568,498,000 | EPS -$5.99 | |
| Axsome Therapeutics, Inc. (AXSM) | 2/18/2025 7:06:47 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $118,766,000 +66.0% | Assets $568,498,000 | EPS -$1.54 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 1/13/2025 7:23:37 AM | View | Financials | Earnings (Prelim) | SEC | Y 2024 | Export Earnings Model | ||||
| Axsome Therapeutics, Inc. (AXSM) | 11/12/2024 9:54:02 AM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $104,762,000 +81.3% | Assets $561,458,000 | EPS -$1.34 | |
| Axsome Therapeutics, Inc. (AXSM) | 11/12/2024 9:31:51 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $104,762,000 +81.3% | Assets $561,458,000 | EPS -$1.34 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 8/5/2024 4:49:16 PM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $87,166,000 +86.7% | Assets $548,226,000 | EPS -$1.67 | |
| Axsome Therapeutics, Inc. (AXSM) | 8/5/2024 7:06:55 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $87,166,000 +86.7% | Assets $548,226,000 | EPS -$1.67 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 5/6/2024 5:36:37 PM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $74,999,000 -20.7% | Assets $545,728,000 | EPS -$1.44 | |
| Axsome Therapeutics, Inc. (AXSM) | 5/6/2024 7:06:20 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $74,999,000 -20.7% | Assets $545,728,000 | EPS -$1.44 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 4/26/2024 5:02:01 PM | View | Proxy | SEC | Y 2023 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 2/23/2024 8:26:02 AM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $270,600,000 +440.8% | Assets $588,236,000 | EPS -$5.27 | |
| Axsome Therapeutics, Inc. (AXSM) | 2/20/2024 7:06:56 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $71,530,000 +193.5% | Assets $588,236,000 | EPS -$2.13 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 1/4/2024 7:12:48 AM | View | Financials | Earnings (Prelim) | SEC | Y 2023 | Export Earnings Model | ||||
| Axsome Therapeutics, Inc. (AXSM) | 11/6/2023 4:57:32 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $57,794,000 +243.1% | Assets $600,857,000 | EPS -$1.32 | |
| Axsome Therapeutics, Inc. (AXSM) | 11/6/2023 7:06:39 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $57,794,000 +243.1% | Assets $600,857,000 | EPS -$1.32 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 8/7/2023 5:35:25 PM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $46,700,000 +429.5% | Assets $611,638,000 | EPS -$1.54 | |
| Axsome Therapeutics, Inc. (AXSM) | 8/7/2023 4:03:18 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $46,700,000 +429.5% | Assets $611,638,000 | EPS -$1.54 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 5/9/2023 6:14:25 AM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $94,576,000 | Assets $389,179,000 | EPS -$0.26 | |
| Axsome Therapeutics, Inc. (AXSM) | 5/8/2023 7:06:40 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $94,576,000 | Assets $389,179,000 | EPS -$0.26 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 4/21/2023 5:24:41 PM | View | Proxy | SEC | Y 2022 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 2/28/2023 6:19:55 AM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $50,037,000 | Assets $331,476,000 | EPS -$4.60 | |
| Axsome Therapeutics, Inc. (AXSM) | 2/27/2023 7:06:09 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $24,371,000 | Assets $331,476,000 | EPS -$1.43 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 11/7/2022 5:25:57 PM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $16,846,000 | Assets $338,957,769 | EPS -$1.07 | |
| Axsome Therapeutics, Inc. (AXSM) | 11/7/2022 7:06:54 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $16,846,000 | Assets $338,957,769 | EPS -$1.07 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 8/23/2022 7:06:46 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $8,820,000 | Assets $180,559,096 | EPS -$1.06 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 8/9/2022 10:23:07 PM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $8,820,000 | Assets $180,559,096 | EPS -$1.06 | |
| Axsome Therapeutics, Inc. (AXSM) | 8/9/2022 7:09:42 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $8,820,000 | Assets $180,559,096 | EPS -$1.06 | Export Earnings Model | |
| Axsome Therapeutics, Inc. (AXSM) | 5/2/2022 5:16:34 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $88,560,261 | EPS -$1.06 | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/2/2022 7:09:44 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $88,560,261 | EPS -$1.06 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 4/22/2022 5:01:32 PM | View | Proxy | SEC | Y 2021 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 3/1/2022 5:24:51 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $87,785,058 | EPS -$3.47 | ||
| Axsome Therapeutics, Inc. (AXSM) | 3/1/2022 7:07:22 AM | View | Financials | Earnings | SEC | Y 2021 | Assets $87,785,058 | EPS -$0.90 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/8/2021 4:21:07 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $116,598,522 | EPS -$0.93 | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/8/2021 7:09:37 AM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $116,598,522 | EPS -$0.93 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/9/2021 4:54:26 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $143,264,750 | EPS -$0.86 | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/9/2021 7:34:20 AM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $143,264,750 | EPS -$0.86 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/10/2021 5:14:53 PM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $166,903,840 | EPS -$0.78 | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/10/2021 4:54:57 PM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $166,903,840 | EPS -$0.78 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 4/23/2021 5:13:37 PM | View | Proxy | SEC | Y 2020 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 3/1/2021 5:15:45 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $186,134,323 | EPS -$2.77 | ||
| Axsome Therapeutics, Inc. (AXSM) | 3/1/2021 7:48:19 AM | View | Financials | Earnings | SEC | Y 2020 | Assets $186,134,323 | EPS -$0.79 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/6/2020 4:54:50 PM | Small | View | Financials | 10-Q/A | SEC | 3Q 2020 ending: 9/30/2020 | Assets $203,629,404 | EPS -$0.61 | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/5/2020 5:32:33 PM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $203,629,404 | EPS -$0.61 | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/5/2020 5:24:40 PM | View | Financials | Earnings | SEC | 3Q 2020 | Assets $203,629,404 | EPS -$0.61 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/10/2020 5:12:46 PM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $190,989,587 | EPS -$0.49 | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/10/2020 8:24:53 AM | View | Financials | Earnings | SEC | 2Q 2020 | Assets $190,989,587 | EPS -$0.49 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/11/2020 5:14:38 PM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $197,800,871 | EPS -$0.88 | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/8/2020 4:50:48 PM | View | Financials | Earnings | SEC | 1Q 2020 | Assets $197,800,871 | EPS -$0.88 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 4/21/2020 5:08:01 PM | View | Proxy | SEC | Y 2019 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 3/12/2020 5:41:43 PM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $220,549,760 | EPS -$2.01 | ||
| Axsome Therapeutics, Inc. (AXSM) | 3/12/2020 7:08:19 AM | View | Financials | Earnings | SEC | Y 2019 | Assets $220,549,760 | EPS -$0.71 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/7/2019 5:17:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $44,439,729 | EPS -$0.56 | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/7/2019 7:20:44 AM | View | Financials | Earnings | SEC | 3Q 2019 | Assets $44,439,729 | EPS -$0.56 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/8/2019 5:08:21 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $54,777,766 | EPS -$0.41 | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/8/2019 7:19:07 AM | View | Financials | Earnings | SEC | 2Q 2019 | Assets $54,777,766 | EPS -$0.41 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/9/2019 7:26:22 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $43,901,088 | EPS -$0.32 | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/9/2019 7:09:24 AM | View | Financials | Earnings | SEC | 1Q 2019 | Assets $43,901,088 | EPS -$0.32 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 4/26/2019 4:07:14 PM | View | Proxy | SEC | Y 2018 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 3/15/2019 6:39:29 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $15,379,279 | EPS -$1.15 | ||
| Axsome Therapeutics, Inc. (AXSM) | 3/14/2019 7:07:16 AM | View | Financials | Earnings | SEC | Y 2018 | Assets $15,379,279 | EPS -$0.32 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/9/2018 4:45:23 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $16,125,828 | EPS -$0.31 | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/9/2018 7:06:58 AM | View | Financials | Earnings | SEC | 3Q 2018 | Assets $16,125,828 | EPS -$0.31 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/8/2018 4:20:54 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $21,725,395 | EPS -$0.32 | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/8/2018 7:07:38 AM | View | Financials | Earnings | SEC | 2Q 2018 | Assets $21,725,395 | EPS -$0.32 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/8/2018 5:04:35 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $27,939,296 | EPS -$0.19 | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/8/2018 7:07:06 AM | View | Financials | Earnings | SEC | 1Q 2018 | Assets $27,939,296 | EPS -$0.19 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 4/30/2018 6:19:05 AM | View | Proxy | SEC | Y 2017 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 3/7/2018 4:57:31 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $35,555,564 | EPS -$1.27 | ||
| Axsome Therapeutics, Inc. (AXSM) | 3/7/2018 7:06:48 AM | View | Financials | Earnings | SEC | Y 2017 | Assets $35,555,564 | EPS -$0.31 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/8/2017 4:41:13 PM | View | Financials | Earnings | SEC | 3Q 2017 | Assets $32,618,112 | EPS -$0.27 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/8/2017 4:36:45 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $32,618,112 | EPS -$0.27 | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/9/2017 4:54:02 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $39,042,861 | EPS -$0.30 | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/9/2017 4:13:43 PM | View | Financials | Earnings | SEC | 2Q 2017 | Assets $39,042,861 | EPS -$0.30 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/9/2017 5:04:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $46,411,558 | EPS -$0.41 | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/9/2017 4:30:57 PM | View | Financials | Earnings | SEC | 1Q 2017 | Assets $46,411,558 | EPS -$0.41 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 4/28/2017 4:39:10 PM | View | Proxy | SEC | Y 2016 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 3/7/2017 5:16:22 PM | View | Financials | Earnings | SEC | Y 2016 | Assets $38,212,608 | EPS -$0.38 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 3/7/2017 4:53:45 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $38,212,608 | EPS -$1.42 | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/14/2016 4:37:32 PM | View | Financials | Earnings | SEC | 3Q 2016 | Assets $34,918,454 | EPS -$0.38 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 11/14/2016 4:02:46 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $34,918,454 | EPS -$0.38 | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/9/2016 6:32:48 PM | View | Financials | Earnings | SEC | 2Q 2016 | Assets $40,007,913 | EPS -$0.36 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/9/2016 4:30:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $40,007,913 | EPS -$0.36 | ||
| Axsome Therapeutics, Inc. (AXSM) | 8/9/2016 4:18:49 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2016 ending: 3/31/2016 | Assets $45,148,244 | EPS -$0.31 | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/11/2016 5:17:12 PM | View | Financials | Earnings | SEC | 1Q 2016 | Assets $45,148,244 | EPS -$0.31 | Export Earnings Model | ||
| Axsome Therapeutics, Inc. (AXSM) | 5/11/2016 4:12:49 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $45,148,244 | EPS -$0.31 | ||
| Axsome Therapeutics, Inc. (AXSM) | 4/27/2016 4:39:29 PM | View | Proxy | SEC | Y 2015 | ||||||
| Axsome Therapeutics, Inc. (AXSM) | 3/29/2016 4:19:36 PM | View | Financials | Earnings | SEC | Y 2015 | Assets $49,076,156 | EPS -$0.23 | Export Earnings Model |